CAPR has been in the news 346% more than usual
Aug 18, 2025, 4:32 PM
-15.16%
What does CAPR do
Capricor Therapeutics, based in Beverly Hills, develops biological therapies for serious medical conditions, focusing on CAP-1002 for Duchenne muscular dystrophy in Phase 3 trials. The company also utilizes exosome technology for various therapeutic applications.
CAPR has been in the news recently: Capricor Therapeutics is facing a class action lawsuit from DJS Law Group for allegedly misleading investors regarding its drug candidate between October 9, 2024, and July 10, 2025. Additionally, The Gross Law Firm is encouraging shareholders to register for the class action after the company's stock price declined from $11.40 to $7.64 following a negative response from the FDA.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.